125 related articles for article (PubMed ID: 34070751)
1. Results of a Prospective Trial to Compare
Baratto L; Toriihara A; Hatami N; Aparici CM; Davidzon G; Levin CS; Iagaru A
Diagnostics (Basel); 2021 May; 11(6):. PubMed ID: 34070751
[TBL] [Abstract][Full Text] [Related]
2. High detection sensitivity and reliable morphological correlation of PET with a silicon photomultiplier for primary tongue squamous cell carcinoma.
Kojima I; Takanami K; Ogawa T; Sakamoto M; Nagai H; Miyashita H; Iikubo M
Ann Nucl Med; 2020 Sep; 34(9):643-652. PubMed ID: 32564300
[TBL] [Abstract][Full Text] [Related]
3. Comparative study of physiological FDG uptake in small structures between silicon photomultiplier-based PET and conventional PET.
Watanabe S; Hirata K; Magota K; Takenaka J; Wakabayashi N; Shinyama D; Yasuda K; Homma A; Kudo K
Ann Nucl Med; 2024 Feb; 38(2):131-138. PubMed ID: 37943379
[TBL] [Abstract][Full Text] [Related]
4. Biodistribution and first clinical results of
Ilhan H; Lindner S; Todica A; Cyran CC; Tiling R; Auernhammer CJ; Spitzweg C; Boeck S; Unterrainer M; Gildehaus FJ; Böning G; Jurkschat K; Wängler C; Wängler B; Schirrmacher R; Bartenstein P
Eur J Nucl Med Mol Imaging; 2020 Apr; 47(4):870-880. PubMed ID: 31492994
[TBL] [Abstract][Full Text] [Related]
5. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Ga-68 DOTA-TATE and Ga-68 DOTA-LAN PET/CT imaging in the same patient group with neuroendocrine tumours: preliminary results.
Demirci E; Ocak M; Kabasakal L; Araman A; Ozsoy Y; Kanmaz B
Nucl Med Commun; 2013 Aug; 34(8):727-32. PubMed ID: 23728519
[TBL] [Abstract][Full Text] [Related]
7.
Duan H; Baratto L; Hatami N; Liang T; Mari Aparici C; Davidzon GA; Iagaru A
Transl Oncol; 2022 Jan; 15(1):101293. PubMed ID: 34823095
[TBL] [Abstract][Full Text] [Related]
8. PET/CT With 68Ga-DOTA-TATE for Diagnosis of Neuroendocrine: Differentiation in Patients With Castrate-Resistant Prostate Cancer.
Gofrit ON; Frank S; Meirovitz A; Nechushtan H; Orevi M
Clin Nucl Med; 2017 Jan; 42(1):1-6. PubMed ID: 27775942
[TBL] [Abstract][Full Text] [Related]
9. Increased [
Firsova M; Treglia G; Sempoux C; Dromain C; Prior JO; Schaefer N; Boughdad S
EJNMMI Rep; 2024 Jun; 8(1):18. PubMed ID: 38910232
[TBL] [Abstract][Full Text] [Related]
10. Head-to-Head Comparison of
Hou G; Zhang Y; Liu Y; Wang P; Xia W; Xing X; Huo L; Li F; Jing H
Front Oncol; 2022; 12():811209. PubMed ID: 35280786
[TBL] [Abstract][Full Text] [Related]
11. The added value of
Kazmierczak PM; Rominger A; Wenter V; Spitzweg C; Auernhammer C; Angele MK; Rist C; Cyran CC
Eur Radiol; 2017 Apr; 27(4):1676-1684. PubMed ID: 27436022
[TBL] [Abstract][Full Text] [Related]
12. Head-to-Head Comparison of
Zhu W; Cheng Y; Wang X; Yao S; Bai C; Zhao H; Jia R; Xu J; Huo L
J Nucl Med; 2020 Jun; 61(6):897-903. PubMed ID: 31676731
[No Abstract] [Full Text] [Related]
13. Compared to conventional PET/CT scanners, silicon-photomultiplier-based PET/CT scanners show higher arterial 18F-FDG uptake in whole-body 18F-FDG-PET/CT.
Kaneko K; Baba S; Isoda T; Ishioka H
Nucl Med Commun; 2021 Dec; 42(12):1361-1368. PubMed ID: 34347656
[TBL] [Abstract][Full Text] [Related]
14. Physiological Biodistribution of
Özgüven S; Filizoğlu N; Kesim S; Öksüzoğlu K; Şen F; Öneş T; İnanır S; Turoğlu HT; Erdil TY
Mol Imaging Radionucl Ther; 2021 Feb; 30(1):39-46. PubMed ID: 33586406
[TBL] [Abstract][Full Text] [Related]
15. [Value of
Zhang S; Wang L; Wang T; Xing HQ; Huo L; Li F
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2018 Dec; 40(6):757-764. PubMed ID: 30606385
[TBL] [Abstract][Full Text] [Related]
16. Ga-68-DOTA-TATE PET/CT for discrimination of tumors of the optic pathway.
Klingenstein A; Haug AR; Miller C; Hintschich C
Orbit; 2015 Feb; 34(1):16-22. PubMed ID: 25264824
[TBL] [Abstract][Full Text] [Related]
17. Comparison between silicon photomultiplier-based and conventional PET/CT in patients with suspected lung cancer-a pilot study.
Economou Lundeberg J; Oddstig J; Bitzén U; Trägårdh E
EJNMMI Res; 2019 Sep; 9(1):35. PubMed ID: 31511997
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 68Ga-DOTANOC and 68Ga-DOTATATE PET/CT within patients with gastroenteropancreatic neuroendocrine tumors.
Wild D; Bomanji JB; Benkert P; Maecke H; Ell PJ; Reubi JC; Caplin ME
J Nucl Med; 2013 Mar; 54(3):364-72. PubMed ID: 23297077
[TBL] [Abstract][Full Text] [Related]
19. The value of [68Ga]Ga-DOTA-TATE PET/CT in diagnosis and management of suspected pituitary tumors.
Novruzov F; Aliyev A; Wan MYS; Syed R; Mehdi E; Aliyeva I; Giammarile F; Bomanji JB; Kayani I
Eur J Hybrid Imaging; 2021 May; 5(1):10. PubMed ID: 34181114
[TBL] [Abstract][Full Text] [Related]
20. Early response assessment and prediction of overall survival after peptide receptor radionuclide therapy.
Huizing DMV; Aalbersberg EA; Versleijen MWJ; Tesselaar MET; Walraven I; Lahaye MJ; de Wit-van der Veen BJ; Stokkel MPM
Cancer Imaging; 2020 Aug; 20(1):57. PubMed ID: 32778165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
